Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives

Therapeutic resistance to anti-oestrogen therapy in breast cancer

Relationship Between Quantitative Estrogen and Progesterone Receptor Expression and Human Epidermal Growth Factor Receptor 2 (HER-2) Status With Recurrence in the Arimidex, Tamoxifen, Alone or in Combination Trial